Abe Yoando Pharma Becomes First Japanese Speaker at Longevity Investors Conference 2026
News related to:Abe Yoando Pharma Co., Ltd · 1 min read
Abe Yoando Pharma, a 295-year-old Japanese pharmaceutical company, has made history by becoming the first Japanese speaker to present at the Longevity Investors Conference 2026 in Gstaad, Switzerland. The conference, which runs from September 14 to 17, 2026, is a prestigious gathering for investors and researchers interested in longevity science.
The company's focus on advancing research and development of high-purity nicotinamide mononucleotide (NMN) and conducting joint scientific studies with academic research institutions underscores its commitment to global healthy aging initiatives. Abe Yoando Pharma was among the 20 finalist teams in the global XPRIZE Healthspan competition, highlighting its significance in the field of longevity science.
Abe, in his presentation, emphasized the unique insights Japan's demographic landscape provides for longevity research.
The global interest in healthy longevity is projected to reach approximately $8 trillion by 2030, according to a UBS Chief Investment Office (CIO) Research Report. Japan, with its aging population, is increasingly recognized as a pivotal region for longevity research and market validation. Abe Yoando Pharma's participation in the conference reflects the growing importance of Asia in the global longevity market.
Founded in 1731 as official physicians to the shogun of the Matsudaira clan, Abe Yoando Pharma has evolved to advance health and longevity science. The company's focus on NMN research and longevity science positions it at the forefront of the industry. Abe Yoando Pharma remains committed to supporting global healthy aging initiatives through rigorous scientific inquiry into cellular mechanisms, including sirtuin genes.
The company's participation in the Longevity Investors Conference 2026 is a significant milestone in its journey to become a leading player in the global longevity market. By presenting at this prestigious event, Abe Yoando Pharma aims to showcase its potential and contribute to the development of infrastructure for an aging world.